Page last updated: 2024-08-05 11:17:41
flavones
A member of the class of flavonoid with a 2-aryl-1-benzopyran-4-one (2-arylchromen-4-one) skeleton and its substituted derivatives.
ChEBI ID: 24043
Members (18)
Member | Definition | Role |
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one | | 2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one |
2-[(4-oxo-2-phenyl-1-benzopyran-3-yl)oxy]acetic acid | | 2-[(4-oxo-2-phenyl-1-benzopyran-3-yl)oxy]acetic acid |
2-[[5-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-4-oxo-2-phenyl-1-benzopyran-7-yl]oxy]acetic acid tert-butyl ester | | 2-[[5-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-4-oxo-2-phenyl-1-benzopyran-7-yl]oxy]acetic acid tert-butyl ester |
2'-hydroxyflavone | | 2'-Hydroxyflavone |
3-methylflavone-8-carboxylic acid | A member of the class of flavones that is flavone substituted at position 3 by a methyl group and at position 8 by a carboxylic acid group. | 3-methylflavone-8-carboxylic acid |
3',4',7-trihydroxyflavone | | 7,3',4'-Trihydroxyflavone |
4'-amino-6-hydroxyflavone | | 2-(4-aminophenyl)-6-hydroxy-1-benzopyran-4-one |
5-hydroxyflavone | | 5-Hydroxyflavone |
5,7,2'-trihydroxyflavone | | 5,7,2'-Trihydroxyflavone |
cochliophilin a | | Cochliophilin A |
flavodic acid | | flavodic acid |
flavone | The simplest member of the class of flavones that consists of 4H-chromen-4-one bearing a phenyl substituent at position 2. | flavone |
flavoxate | A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol. | flavoxate |
Isolicoflavonol | | Isolicoflavonol |
Licoflavone A | | Licoflavone A |
Licoflavone B | | Licoflavone B |
morusinol | | Morusinol |
Norartocarpetin | | Norartocarpetin |
Research
Studies (789)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 181 (22.94) | 18.7374 |
1990's | 64 (8.11) | 18.2507 |
2000's | 159 (20.15) | 29.6817 |
2010's | 319 (40.43) | 24.3611 |
2020's | 66 (8.37) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 24 (2.67%) | 5.53% |
Reviews | 33 (3.67%) | 6.00% |
Case Studies | 8 (0.89%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 833 (92.76%) | 84.16% |